Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Applied Optics|November 18, 2014
Analytical solution of the transient temperature profile in gain medium of passively Q-switched microchip laserXiahui Han, Jianlang Li
Amino Acids|August 12, 2023
Research progress on the role of cationic amino acid transporter (CAT) family members in malignant tumors and immune microenvironmentShijing You, Xiahui Han, Yuance Xu, et al.
Journal of Biophotonics|August 20, 2025
Comparative Analysis of Reflectance Confocal Microscopy and Multiphoton Microscopy in Basal Cell Carcinoma DiagnosisWenwen Zhong, Lingyang Long, Ying Feng, et al.
Cancer Medicine|May 16, 2024
High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMTShijing You, Xiahui Han, Yuance Xu, et al.
Scientific Reports|October 3, 2024
SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogrammingYuance Xu, Xiahui Han, Shijing You, et al.
Scientific Reports|February 5, 2025
Multiphoton imaging-based quantifiable collagen signatures for predicting outcomes in patients with pancreatic ductal adenocarcinomaXiwen Chen, Jikui Miao, Xingxin Huang, et al.
Frontiers in Oncology|January 14, 2025
Clinicopathological characteristics of invasive stratified mucinous carcinoma of the cervix and the expression and clinical significance of SLC7A11, SLC3A2 and PD-L1Changyu Lu, Wei Zhu, Xiahui Han, et al.
BMC Cancer|May 29, 2024
Prognostic significance of collagen signatures in pancreatic ductal adenocarcinoma obtained from second-harmonic generation imagingXiwen Chen, Linying Chen, Jikui Miao, et al.
Scientific Reports|June 24, 2026
SLC45A4 expression in cancer-associated fibroblasts is associated with epithelial ovarian cancer progression and HIF-1α-glycolysis signaling activationYuance Xu, Yuke Mao, Danting Sun, et al.
International Journal of Biological Macromolecules|May 11, 2024
Injectable bio-multifunctional hyaluronic acid-based hydrogels loaded with poly ADP-ribose polymerase inhibitors for ovarian cancer therapyXiahui Han, Guotai Li, Shijing You, et al.
Pageof 2